Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY Low LDL Target, No Clinical Gain in Non-CAD Diabetes: EMPATHY
Statins aimed at reducing LDL-C to less than 70 mg/dL didn ' t cut cardiovascular events, but an intriguing post hoc finding suggests there may yet be benefit, in this trial of patients with diabetic retinopathy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Endocrinology | Health | Heart | Statin Therapy